Open access
1,853
Views
2
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism
Drug–drug interaction potential and clinical pharmacokinetics of enerisant, a novel potent and selective histamine H3 receptor antagonist
Shuichi Terasakaa Drug Metabolism and Pharmacokinetics, Drug Safety and Pharmacokinetics Laboratories, Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, JapanCorrespondence[email protected]
, Kenji Hachiumaa Drug Metabolism and Pharmacokinetics, Drug Safety and Pharmacokinetics Laboratories, Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Japan
, Yoko Manob Development Headquarters, Taisho Pharmaceutical Co., Ltd., Tokyo, Japan
, Koichi Onishib Development Headquarters, Taisho Pharmaceutical Co., Ltd., Tokyo, Japan
, Iwao Kitajimab Development Headquarters, Taisho Pharmaceutical Co., Ltd., Tokyo, Japan
, Izumi Nishinob Development Headquarters, Taisho Pharmaceutical Co., Ltd., Tokyo, Japanhttps://orcid.org/0000-0002-7754-1986
& Hiromi Endoa Drug Metabolism and Pharmacokinetics, Drug Safety and Pharmacokinetics Laboratories, Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Japan
show all
Pages 786-795
|
Received 24 Feb 2021, Accepted 13 Apr 2021, Published online: 28 Apr 2021
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.